Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 4Breast 3Plasma cell 2CNS 2Thoracic 1Sarcoma 1Other neoplasm 1Myeloid 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 211Leukemia, Myeloid, Acute 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 162Leukemia 125Lymphoma, Non-Hodgkin 112Hodgkin Disease 102Leukemia, Lymphocytic, Chronic, B-Cell 99Multiple Myeloma 97Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Lymphoma 88Myeloproliferative Disorders 87Lymphoma, Follicular 72Leukemia, Myelomonocytic, Chronic 72Leukemia, Myeloid, Chronic-Phase 71Lymphoma, Mantle-Cell 70Burkitt Lymphoma 67Leukemia, Myeloid, Accelerated Phase 65Primary Myelofibrosis 62Lymphoma, B-Cell, Marginal Zone 61Lymphoma, Large B-Cell, Diffuse 60Blast Crisis 53Anemia, Refractory, with Excess of Blasts 51Lymphoma, Large-Cell, Immunoblastic 50Congenital Abnormalities 50Neoplasms, Plasma Cell 47Myelodysplastic-Myeloproliferative Diseases 45Dendritic Cell Sarcoma, Interdigitating 41Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 38Graft vs Host Disease 38Leukemia, Biphenotypic, Acute 37

Interventions

Amifostine 2sargramostim 1Mitoxantrone 1Epoetin Alfa 1Cytarabine 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cyclophosphamide × Myeloid × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡